MBX Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBX and other ETFs, options, and stocks.About MBX
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio.
CEOPeter Kent Hawryluk
CEOPeter Kent Hawryluk
Employees43
Employees43
HeadquartersCarmel, Indiana
HeadquartersCarmel, Indiana
Founded2018
Founded2018
Employees43
Employees43
MBX Key Statistics
Market cap1.44B
Market cap1.44B
Price-Earnings ratio-13.36
Price-Earnings ratio-13.36
Dividend yield—
Dividend yield—
Average volume852.84K
Average volume852.84K
High today$32.07
High today$32.07
Low today$29.98
Low today$29.98
Open price$29.98
Open price$29.98
Volume823.66K
Volume823.66K
52 Week high$34.83
52 Week high$34.83
52 Week low$4.81
52 Week low$4.81
Stock Snapshot
The current MBX Biosciences(MBX) stock price is $31.97, with a market capitalization of 1.44B. The stock trades at a price-to-earnings (P/E) ratio of -13.36.
On 2025-12-06, MBX Biosciences(MBX) stock traded between a low of $29.98 and a high of $32.07. Shares are currently priced at $31.97, which is +6.6% above the low and -0.3% below the high.
The MBX Biosciences(MBX)'s current trading volume is 823.66K, compared to an average daily volume of 852.84K.
In the last year, MBX Biosciences(MBX) shares hit a 52-week high of $34.83 and a 52-week low of $4.81.
In the last year, MBX Biosciences(MBX) shares hit a 52-week high of $34.83 and a 52-week low of $4.81.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
0%
Sell
11.1%
People also own
Based on the portfolios of people who own MBX. This list is generated using Robinhood data, and it’s not a recommendation.